Introduction
============

The existence of embryonic macrophage-like cells has been reported in all animal models and its conservation suggests important roles during development. Studies in zebrafish and *Xenopus* have provided important insights into the mechanisms responsible for primitive hematopoiesis.^[@B1][@B2]--[@B3]^ Until recently, however, most of these studies have focused on the specification and differentiation of primitive erythrocytes. Comparatively, little is known about the mechanisms and gene networks responsible for the development of primitive macrophages and neutrophils. In *Xenopus*, primitive myeloid cells arise from the anterior ventral blood island (aVBI), the embryonic region equivalent to the zebrafish anterior lateral plate mesoderm (ALPM) and the mammalian yolk sac. In zebrafish, the ALPM, which contains the primitive myeloid-forming compartment, is physically separated from the primitive erythroid-forming compartment, the posterior lateral plate mesoderm (PLPM). However in *Xenopus*, the primitive myeloid-forming aVBI, is juxtaposed next to the erythroid-forming compartment, the posterior ventral blood island (pVBI). In both fish and frogs, these tissues arise from distinct locations in the embryo. Whereas the pVBI and PLPM arise from ventral gastrula mesoderm, the aVBI and ALPM arise from dorsal gastrula mesoderm.^[@B4][@B5]--[@B6]^ Experiments using a variety of model organisms have pointed to a conserved gene regulatory network leading to hematopoietic specification, with the transcription factor *scl* representing one of the central genes in the hematopoietic specification cascade.^[@B7][@B8][@B9]--[@B10]^ In frog embryos, *scl* expression appears first in the aVBI and only at a later time point in the pVBI with its characteristic V shape. At stage 20, as *scl* expression is down-regulated and restricted to bilateral stripes in the aVBI, *scl* is concomitantly up-regulated in the pVBI forming the tissue that will give rise to the first erythroid cells. The analysis of gene expression profiles and distinct origins of the aVBI and pVBI reveals 2 distinct temporal hematopoietic events that occur in juxtaposed mesodermal tissues. The aVBI tissue at the neurula stage also expresses other transcription factors typical of both hematopoietic and endothelial lineages such as *fli1, lmo2, runx1*, or *hhex* and the coexpression of these markers represents the hemangioblast stem cell--like state.^[@B11][@B12][@B13][@B14]--[@B15]^ Very little is know about the transcriptional regulation that controls primitive myelopoiesis in *Xenopus*, however it has been shown in zebrafish that the balance between primitive myelopoiesis and primitive erythropoiesis is dictated by the antagonistic interplay between the activity of 2 transcription factors *spi1* (also known as *pu.1*), which promotes myelopoiesis, and *gata1*, which promotes erythropoiesis.^[@B16]^ To date, neither *spi1* nor any other specific regulator of primitive myeloid development has been characterized in *Xenopus*. In this study, we identified *spib*, a gene related to *spi1*, and show that *spib* marks primitive myeloid cell progenitors and that it is indispensable for primitive myeloid development. Our data indicate that *spib* acts upstream of *spi1* in the molecular hierarchy of primitive myeloid development and suggest that *spib* is necessary for the transition from a hemangioblast-like cell state to differentiation of myeloid lineages

Methods
=======

Bioinformatics of *spib* and *spi1*
-----------------------------------

*spib* and *spi1* genomic sequences were identified in scaffold 106 and 907, respectively. Information collated from Joint Genome Institute (<http://genome.jgi-psf.org/Xentr4>),^[@B17]^) Ensembl (<http://www.ensembl.org>),^[@B18]^ and Metazome (<http://www.metazome.net>)^[@B19]^ was used to determine transcript structure and synteny between known vertebrate *spib* and *spi1* genes. Protein and ETS domain sequence alignments were performed using ClustalW^[@B20]^ and TreeView X,^[@B21]^ and PEST sequences were determined with PESTfind algorithm.^[@B22]^ Gene names and symbols abide by the *Xenopus* nomenclature guidelines,^[@B23],[@B24]^ which suggest that gene names and symbols should correspond to the gene names and symbols of the human orthologs. In addition, we have attempted to use primarily the official names and symbols of the genes for each of the mentioned model organisms.

Whole mount in situ hybridization
---------------------------------

Whole mount in situ hybridization (WMISH) was performed using standard protocols^[@B26]^ using a BioLane HTI robot (Hölle & Hüttner AG, Tübingen, Germany, <http://www.h-net.com>). Antisense probes were synthesized using MegaScript kit (Ambion, Austin, TX) and Digoxigenin (Roche, Indianapolis, IN) and purified on Bio-Spin columns (BioRad, Hercules, CA). BM Purple (Roche) was used for the substrate and the embryo pigment was bleached under strong light in 0.5 × SSC, 5% formamide, 2% H~2~O~2~. The following orthologs of hematopoietic relevant genes were used for antisense probe synthesis: *X laevis spiba:* IMAGE 5537169, *Sal*I, T7; *spibb:* IMAGE 6957053, *Sal*I, T7; *xpox2: Sal*I, T7^[@B27]^; *scl: Xho*I, SP6^[@B11]^; *runx1*, *Sal*I, T7^[@B28]^; *X tropicalis spib:* IMAGE 7023083, *Eco*RV (or *Sac*I to eliminate the ETS domain), T7; *mpo (xpox2):* IMAGE 5336501, *Sal*I, T7; *cebpa:* TEgg058d02, *Eco*RI, T7; *spi1:* IMAGE 7695805, *Sal*I, T7; *mmp7:* IMAGE 7005633, *Eco*RI, T7*; lcp1(l-plastin):* IMAGE 7022626, *Eco*RV, T7; *scl:* TTbA055c20, *Eco*RI, T7; *lmo2:* IMAGE 7002909, *Eco*RV, T7; *globin:* TTpA004i19, *Eco*RI, T7*; fli1:* IMAGE 7621709, *Sma*I, T7*; flk1:* IMAGE 7620420, *Sal*I, T7; and *gata1:* IMAGE 8953859, *Sma*I, T7. Image acquisition was done using a Leica MZAPO stereoscope and Northern Eclipse software (Empix Imaging, Mississauga, ON).

Embryo manipulations
--------------------

*Xenopus laevis* embryos were used in homotypic transplants and kept at 16°C unless stated otherwise. Microruby, a fluorescent cell tracer dextran was injected into one-cell embryos (10 nL, 2%; Invitrogen, Eugene, OR; D7162). aVBIs were transplanted between stages 14 and 16; donor and host embryos were placed side by side, ventral side up, in adjacent chambers made with a fire-polished glass Pasteur pipette into plasticine coated with 0.1% BSA (nontoxic, nonsticky; Eberhard Faber, Neumarkt, Germany). aVBIs were cleanly cut using a Gastromaster (Xenotek Engineering, Belleville, IL), maintaining consistent sizes, exchanged between donor and host embryos and left to heal undisturbed in 0.4 × MMR, 1% Ficoll for 2 to 3 hours. Imaging was performed in anesthetized embryos (\< 10 minutes, 0.02% MS222) with an Olympus IX70 inverted fluorescent microscope (Watford, United Kingdom), using Northern Eclipse software for time-lapse image acquisition, and movies were assembled using ImageJ software (National Institutes of Health, Bethesda, MD). Embryonic wounds were made in sterile 0.1 × MMR with a Gastromaster tip. Infection assays were performed by injection of a suspension of *E coli* expressing GFP (a gift from Jordan Raff).

Morpholino oligonucleotides
---------------------------

Loss-of-function experiments were performed in the diploid frog *Xenopus tropicalis* kept at 23°C. The following antisense morpholino oligonucleotides (MO) were obtained against *Xenopus tropicalis spib* (GeneTools, Philomath, OR): ATG\*\*\* (3-mismatch): ACGGTA CTGACT CCAACC TGACCAT; ATG: ACCGTA GTGAGT CCAAGC TGAGCAT; and e1i1 (exon1--intron1): CTAAAG CCCATC ACTTAC CGTAGTG. They were dissolved and stored according to the manufacturer\'s instructions and injected at the 1-cell stage; embryos were kept in 0.01 × MMR.

RNA analysis
------------

mRNA was extracted using Trizol from a pool of 5 *Xenopus tropicalis* embryos. SuperScript II (Invitrogen) was used to do reverse cDNA synthesis and the primers used were as follows: *spib* forward: TGCCCA CAAAAT GCTCAG CTTG, *spib* reverse: TGTCGT ATGTCT CGTAAC CAGG; *spi1* forward: AGAAAC ACACAG AAATCC CTTTATG, *spi1* reverse: CGCTTG ATGTAA GAAACC CAATAAG; *cebpa* forward: GGGATG TGCCCT TTATTG TCAG, *cebpa* reverse: GCAAGG ATGTCC AACATG AAGC; *mpo* forward: AACAGA CCCTGG ACAACC AACG, *mpo* reverse: ACCTGG CTGGCA TCAACA TAAG; *mmp7* forward: CCAAGT GGTAGA CACCGC AATAC, *mmp7* reverse: ACATCA AGGCTC GTGGGT CAGTAG; *lcp1* forward: GAGACC GAGAAA CTCAAC AACGC, *lcp1* reverse: CCCATA AGGCAA GCAAAG ACTGTC; and *globin* forward: ACAAAC AGGGCA TTGATT AATGCT, *globin* reverse: AATGTC TCCGCT GTCTCT GGA. For semiquantitative reverse-transcription--polymerase chain reaction (RT-PCR) analysis, the number of cycles required for each primer pair was determined empirically and controls without reverse transcriptase were included as well as cDNA dilutions to ensure that the PCR reaction was in the log-linear range. Real-time quantitative RT-PCR (qRT-PCR) analysis was performed in individual *Xenopus tropicalis* embryos using an Opticon II (MJ Research, Watertown, MA) adding to the PCR mix a 1:2000 dilution of SYBR (Sigma-Aldrich, St Louis, MO). For each primer pair, the PCR product was examined by gel electrophoresis and its melting curve to ensure a single fragment of the predicted molecular weight. The data for each sample were normalized to the expression level of ornithine decarboxylase (ODC) and calculated by the 2^−ΔΔCt^ method, normalized to expression levels at stage 10.

Sudan Black
-----------

Neutrophils can be visualized using Sudan Black histochemical stain in whole mount embryos (Sigma-Aldrich). Briefly, after 1 hour of fixation embryos were stained, washed in 100% EtOH, and then hydrated to PBS, washed, and bleached under strong light (0.5 × SSC, 5% formamide, 2% H~2~O~2~).

Results
=======

Isolation of *spib*
-------------------

In an unrelated screen,^[@B29]^ we identified a novel transcript expressed in the anterior ventral blood islands at neurula stage ([Figure 1](#F1){ref-type="fig"}). In tailbud embryos, expression of this gene was observed in a punctate pattern reminiscent of primitive myeloid markers such as XLURP-1, XPOX2, and MMP7.^[@B27],[@B30],[@B31]^ Sequence analysis showed that this gene belonged to the spi subfamily of ETS transcription factors, with a C-terminal ETS domain and a PEST domain ([Figure 1](#F1){ref-type="fig"}A,B). This architecture is conserved in all members of the spi subfamily, of which *spi1* (also known as *pu.1* and *Sfpi1*) is the most well-characterized member. To determine to which member of the spi subfamily our gene belonged, we used genome and synteny information to conclude that our gene is the *Xenopus tropicalis* ortholog of *spib*, given that it is located between the *pold1* and *mybpc2* genes ([Figure 1](#F1){ref-type="fig"}C). We also isolated the *Xenopus tropicalis* ortholog of *spi1*, which shows remarkable synteny with the human, mouse, and chick genomes ([Figure 1](#F1){ref-type="fig"}C). Interestingly, however, we noted that *spib* sequences appear to be absent from the chicken and fish genomes.

![***Xenopus spib identification*.** (A) Conserved protein motifs in *spib* and *spi1*; the PEST degradation domain and ETS DNA-binding domain. (B) ClustalW tree alignment on vertebrate *spib* and *spi1* protein sequences and percentage identity over their entirety and DNA-binding domains. (C) Genome organization around the known vertebrate *spib* and *spi1* genes, showing synteny between various vertebrate genomes. Genes shown in the same color represent putative orthologous genes. Expression pattern of *Xenopus tropicalis spib* and (D-G) *Xenopus laevis spib* paralogs (*SpiBa* and *SpiBb*, H-J) is indistinguishable and marks a population of primitive myeloid progenitors in the anterior ventral blood islands (aVBIs). *spib* expression is transient and first detected at stage 17. (F) Cleared embryo shows only mesodermal expression, and (J) *spib* expression is eventually down-regulated after *spib*-expressing cells associate with vitelline veins (arrowheads). Anterior is to the left, and dorsal to the top in all lateral views; panels D, G, and I,J represent ventral views. The following database sequences were used: *Hs spib* Q01892, *Mm spib* O35906, *Xl spiba* BC046671, *Xl spibb* BC130210, *Xt spib* IMAGE 7023083, *Hs spi1* P17947, *Mm spi1* P17433, *Gg spi1* NP_990354, *Xt spi1* BC098077, and *Dr spi1* CAD58735 (outgroup NP_001008139 and P14921).](zh80180824210001){#F1}

Using WMISH, we determined the expression pattern of *Xenopus laevis spib* paralogs and *Xenopus tropicalis spib*, from the neurula stages through the tailbud stages ([Figure 1](#F1){ref-type="fig"}D-J). These data revealed that, in both species, *spib* was expressed in the progenitors of primitive myeloid cells, originating from the aVBI from stage 17. At the tailbud stages, *spib*-expressing cells dispersed throughout the embryo before the establishment of a functional vasculature ([Figure 1](#F1){ref-type="fig"}). In tadpoles, a subset of *spib*-expressing cells was observed associated with the nascent vitelline veins that surround the pVBI ([Figure 1](#F1){ref-type="fig"}J red arrowheads). Soon after, the expression of *spib* was down-regulated as myeloid cells differentiate (data not shown).

Primitive myeloid cell behavior
-------------------------------

To analyze the initial steps of primitive myeloid cell migration, we performed homotypic transplantations of aVBIs from microruby-injected embryos into stage-14 and -16 host embryos. This allowed us to observe the migration of primitive myeloid cells away from the aVBI, using time-lapse fluorescence video microscopy ([Figure 2](#F2){ref-type="fig"}). By stages 19 and 20, migration of microruby-positive cells was observed as single individual cells leaving the transplant ([Figure 2](#F2){ref-type="fig"}D,E; Videos S1,S2, available on the *Blood* website; see the Supplemental Materials link at the top of the online article). The overall morphology and cell population behavior throughout the colonization process was very dynamic. It started with a "blebbing" cell behavior with low motility as cells left the aVBI, changing to a behavior with higher protrusive activity and low migratory speeds (Videos S1,S2). As the distance from the aVBI increased the cells changed to a highly motile bipolar behavior, which allowed the cells to colonize the whole embryo within 4 to 8 hours ([Figure 2](#F2){ref-type="fig"}E; Video S3). Once that process was completed, a third phase ensued as isolated primitive myeloid cells began to patrol the embryo, coincident with less protrusive activity in the cells. Throughout these migratory behaviors, primitive myeloid cells were capable of undergoing cell divisions and some were phagocytic (data not shown). In summary, the behavior of these cells is consistent with the previously described *Xenopus* primitive macrophages or zebrafish primitive macrophages and neutrophils.^[@B27],[@B31][@B32][@B33]--[@B34]^

![**Primitive myeloid migration time-lapse video microscopy**. (A) Experimental setup, stage-14 to -16 anterior ventral blood islands were transplanted from microruby-injected to noninjected embryos. Transplanted cells become migratory and leave the transplant to colonize the embryo in 4 to 8 hours. Throughout this period, primitive myeloid cells show different behaviors (Videos S1--S3). (B,C) Stage-18 brightfield/fluorescent composite of transplanted embryos. (D,E) Stills from supplementary movies. (Panel D and Video S2) Ventral view of primitive myeloid cells leaving the transplanted aVBI with "blebbing" behavior and low migratory speeds. (Panel E and Video S3) Primitive myeloid cells leaving the transplanted aVBI (stage 26, lateral view). At this stage, cells acquire elongated cell morphology and higher motility. Large dashed line shows the embryo contour, and the light dashed square shows the enlarged region shown in still frames. Colored arrowheads point and track the same cell. (D,E) Anterior view is shown to the left; dorsal, to the top. Time is shown in minutes. Images in panels B and C were obtained on a fluorescence stereoscope Leica MZ FLIII (Wetzlar, Germany) attached to a Sony CCD camera DXC-950 image capture system controlled by Northern Eclipse software 7.0 (Empix Imaging, Mississauga, ON). For panels D and E, the same image capture system was attached to an Olympus IX70 inverted fluorescent microscope; 0.1× MMR was used as imaging medium. (D) Total magnification 300× objective (Olympus LCPlan 20×/0.4 NA). (E) Total magnification 40× objective (Olympus UPlanFL 4×/0.13 NA). Photoshop CS2 (Adobe Systems, San Jose, CA) or ImageJ 1.38 (National Institutes of Health, Bethesda, MD) were used for image or time-lapse video processing.](zh80180824210002){#F2}

Primitive myeloid cell are recruited to embryonic wounds
--------------------------------------------------------

The recruitment of myeloid cells to sites of injury is a hallmark of the inflammatory and wound-healing responses and can be used as a measure of functional myeloid cells in embryos. Within this framework, we sought to test the function of primitive myeloid cells by evaluating whether they are able to respond to wounds or *E coli* infection in *Xenopus* tailbud-stage embryos before a functional vasculature is established. We found that primitive myeloid cells, as identified by the expression of *spib* and *mpo* but not *scl*, were efficiently recruited to *Xenopus* embryonic wounds in tailbud-stage embryos ([Figure 3](#F3){ref-type="fig"}A-F). Indeed, primitive myeloid cells started to migrate toward wound sites within 2 to 3 minutes after injury or infection, with recruitment of myeloid cells to the wound edge completed by 3 hours ([Figure 3](#F3){ref-type="fig"}; Video S4). In summary, primitive myeloid cells are capable of responding to wounding or infection before a functional vasculature is established in the embryo, demonstrating that primitive myeloid cells differentiate and become functional very early in embryos.

![**Recruitment of primitive myeloid cells to embryonic wound sites in *Xenopus laevis***. *spib* (A-C), *mpo (XPOX2*) (D,E), and *scl* (G-I) whole mount in situ hybridization in wounded embryos. Three hours is sufficient for the recruitment of myeloid cells expressing *spib* or *mpo* to the scrape wound outline (dashed line contour in the inset). *scl*-expressing cells are not recruited to the wound site, and primitive myeloid cell recruitment occurs before the appearance of a fully functional vascular network.](zh80180824210003){#F3}

Characterization of primitive myeloid molecular markers in *Xenopus tropicalis*
-------------------------------------------------------------------------------

To study the function of *spib* in primitive myeloid differentiation, we isolated and determined the temporal and spatial pattern of expression of the following primitive myeloid molecular markers in *Xenopus tropicalis: cebpa, spi1, mpo*, and *mmp7* ([Figure 4](#F4){ref-type="fig"}A-E). Expression of all these markers was restricted to the aVBI at neurula stages, whereas at tadpole stages expression was observed as a characteristic myeloid punctate pattern. Noticeably, *spib* was expressed earlier than all the markers, with the exception of *cebpa* (CCAAT/enhancer binding protein alpha) ([Figure 4](#F4){ref-type="fig"}A-E), suggesting that *spib* is one of the earliest markers of primitive myeloid cells.

![***Xenopus tropicalis* primitive myeloid marker expression analysis by RT-PCR and WMISH**. (A-F) *spib, spi1, cebpa, mpo, mmp7*, and *globin* single embryo qRT-PCR and ventral views of WMISH at stages 18 and 23. Among the transcription factors, (A) *spib* is the first to be specifically expressed in primitive myeloid cells, (B) followed by *spi1*. (C) Earlier expression of *cebpa* is due to its broad mesodermal expression before its restriction to the aVBI. (D) *mpo* is a neutrophil marker; (E) *mmp7*, a macrophage marker; and (F) *globin*, a erythroid marker. Error bars represent the SD of at least 3 independent experiments.](zh80180824210004){#F4}

In zebrafish, *spi1 (pu.1)* marks primitive myeloid cells and acts as a key regulator of primitive myeloid development.^[@B16],[@B35][@B36]--[@B37]^ We found that the *Xenopus tropicalis* ortholog of *spi1* was also expressed in primitive myeloid cells ([Figure 4](#F4){ref-type="fig"}B). However, qRT-PCR data showed that the onset of *spi1* expression begins several stages after the onset of *spib* expression (ie, stage 18 for *spi1* versus stage 15 for *spib*; [Figure 4](#F4){ref-type="fig"}A,B). Furthermore, *spib* transcripts could be robustly detected by WMISH at stage 17, whereas *spi1* could be detected only 3 hours later at stage 20. *Xenopus tropicalis mpo* is the ortholog of *X laevis* XPOX2 and zebrafish *mpx*. It encodes a myeloperoxidase, which is expressed in neutrophil granules during embryogenesis and in adult mammalian granulocytes.^[@B27],[@B38]^ Using double WMISH, we found that *mpo* was expressed in the aVBI in an overlapping pattern to that of *spib*, suggesting that both genes are expressed in the same cells (Figure S1). *mpo* was also the earliest specific myeloid marker after *spib* ([Figure 4](#F4){ref-type="fig"}D). Therefore, we have used *mpo* as an early differentiation marker of primitive myeloid cells, possibly of the granulocytic lineage. As a primitive macrophage marker we have used *mmp7*, a secreted metalloproteinase involved in extracellular matrix remodeling. Homologues of this gene have been previously used as macrophage differentiation markers.^[@B30],[@B33],[@B39],[@B40]^ Relative to other myeloid markers, *mmp7* is expressed considerably later and with a similar timing to the erythroid lineage marker, *globin* ([Figure 4](#F4){ref-type="fig"}E,F). In general, our findings on the timing of expression and the functional assays we have performed suggest that primitive myeloid cells differentiate and are functional before primitive erythroid cells.

*spib* is required for primitive myeloid cell differentiation
-------------------------------------------------------------

The timing and pattern of *spib* expression prompted us to characterize its role during primitive myelopoiesis in *Xenopus tropicalis*. We used an antisense morpholino oligonucleotide loss-of-function approach designed to block either the translation or splicing of *spib* transcripts (^spib^ATG~10ng~ and ^spib^e1i1~10ng~, respectively; Figure S2A). Embryos injected with morpholinos targeting translation or splicing of *spib* appeared morphologically normal at tailbud stages ([Figure 5](#F5){ref-type="fig"}). However, injection of both types of MOs resulted in an elimination or severe reduction in the expression of all primitive myeloid markers tested, with the exception of *cebpa* ([Figure 5](#F5){ref-type="fig"}). *spi1, mpo*, and *mmp7* and other myeloid markers such as *lcp1 (X tropicalis l-plastin)* were all absent or markedly reduced from late neurula to tailbud stages, when examined by either WMISH or semiquantitative RT-PCR ([Figure 5](#F5){ref-type="fig"} and data not shown). Given that both morpholino oligonucleotides gave rise to very similar repression of the myeloid markers, whereas the mismatch negative control oligonucleotide (ATG\*\*\*) had no effect, we conclude that the MO injection resulted in a specific inhibition of *spib* function. As expected, the ATG morpholino had little effect on the *spib* RNA levels as judged by RT-PCR, whereas the splicing morpholino significantly decreased the expression of mature *spib* transcripts (compare [Figure 5](#F5){ref-type="fig"}P and [5](#F5){ref-type="fig"}Q). However, based on in situ hybridization, we observed considerably fewer *spib*-positive cells outside of the aVBI region in ^spib^ATG~10ng~ morphants, suggesting that once myeloid development was blocked the cells did not migrate properly.

![***spib* is necessary for primitive myeloid differentiation**. *spib*-depleted embryos show absence or reduced expression of *mpo, spi1*, and *mmp7* but not *cebpa*. (A-O) WMISH and (P,Q) RT-PCR analysis on *spib* ATG and e1i1 morphants. ATG\*\*\* is a 3-mismatch ATG morpholino. (P) *spib* ATG morpholino reduces but does not eliminate all *spib* transcripts, (Q) whereas *spib* e1i1 morpholino eliminates functional *spib* mRNA at 10 ng. (A-F) Severe reduction on the number of *spib*- and *mpo*-expressing cells and (J-O) marked absence of *spi1* and *mmp7* expression on *spib* morphants. (G-I) Under the same experimental conditions, *cebpa*-expressing cells are not affected. All embryos are shown in lateral views with anterior to the left. The number of representative embryos is shown at the bottom right corner of each panel.](zh80180824210005){#F5}

Of all the markers we analyzed, only *cebpa* expression was relatively unaffected by *spib* loss of function, although *cebpa*-expressing cells were found to cluster around the vitelline veins ([Figure 5](#F5){ref-type="fig"}M-O red arrowheads). Together with the fact that *cebpa* is expressed prior to *spib*, this result suggests that *cebpa* may act upstream of *spib* in the hierarchy of myeloid development. However, the markers expressed well after *spib*, such as *spi1* and *mmp7*, are particularly sensitive to *spib* depletion ([Figure 5](#F5){ref-type="fig"}G-L,P-Q; [Figure 6](#F6){ref-type="fig"}D-I). This demonstrates that *spib* is necessary for *spi1* and *mmp7* expression, suggesting that *spib* functions upstream of *spi1* and *mmp7*. Furthermore, loss of primitive myeloid cell differentiation was sustained until tailbud stages as observed by the reduction in the number of neutrophils at stage 42 (Figure S2B).

![**Effect of *spib* knockdown in primitive myeloid progenitors**. (A-I) Primitive macrophages defined by the expression of *spi1* and *mmp7* are absent from *spib*-depleted embryos. (J-L,O-Q,T-V) WMISH analysis of aVBI in *spib* morphants; at the earliest point we can identify a pool of primitive myeloid progenitors by the coexpression of *spib, mpo*, and *cebpa*. (M,R,W) Quantification of the number of embryos that express *spib, mpo*, and *cebpa* and (N,S,X) size of primitive myeloid progenitor pool, by the area of tissue-expressing progenitor markers. Error bars represent the SD of the number of embryos analyzed (n). (O) Amount of tissue was calculated using area ratios of a and a′. Similar results were obtained in either ATG or e1i1 morphants and are in contrast with the uninjected and ATG mismatch control group (CTL). Student *t* test *P* values lower than .001 are marked as \* and considered statistically significant; *P* values higher than .05 are not statistically significant and marked as \*\*\*.](zh80180824210006){#F6}

We next asked when could we first detect the effect of knocking down *spib* function during primitive myeloid differentiation? For this, we focused on the earliest time point at which these cells can be molecularly identified in *Xenopus tropicalis:* that is, stage 18, using *spib, mpo*, and *cebpa* as markers; stage 20, using *spi1* as a marker; and stage 23, using *mmp7* as a marker. As before, the most significantly affected markers were *spi1* and *mmp7*, which are also the markers that are expressed the latest, and both were absent in all the experimental embryos ([Figure 6](#F6){ref-type="fig"}A-I). This finding is interesting in light of previous reports suggesting that *spi1* acts as a master regulator of not only adult myelopoiesis but also of primitive myelopoiesis.^[@B16],[@B41]^ In contrast, the effects on earlier markers were more variable. We quantified both the percentage of embryos expressing *spib, mpo*, or *cebpa*, as well as the area of aVBI tissue expressing those markers in control versus *spib*-depleted embryos ([Figure 6](#F6){ref-type="fig"}J-X). The majority of *spib*-depleted embryos fail to express either *spib* or *mpo* ([Figure 6](#F6){ref-type="fig"}M,R). However, in the few embryos that still express *spib* and *mpo* (20% to 40% depending on the morphant), the area of expression is significantly reduced ([Figure 6](#F6){ref-type="fig"}K-N,P-S; Student *t* test, *P* \< .001). This suggests that although *spib* function may not be absolutely required for its own initial expression, it may play an important role in maintaining its own transcription and that of *mpo*. Conversely, *cebpa* expression was neither affected nor reduced in *spib* morphants (Student *t* test, *P* \> .05), demonstrating that *spib* was not required for maintenance or initiation of *cebpa* expression ([Figure 6](#F6){ref-type="fig"}T-X). In light of these results, we conclude that *spib* is required very early in the differentiation of primitive myeloid progenitors in *Xenopus*.

*spib* morphants do not have expanded posterior blood islands
-------------------------------------------------------------

In *Xenopus*, primitive myelopoiesis and erythropoiesis occur in juxtaposed locations with distinct developmental timing---the aVBI earlier and pVBI later. Previous experiments in zebrafish have suggested a cross-regulation in the development of these lineages between myelopoietic and erythropoietic compartments, including the negative cross-regulation of *spi1* and *gata1*.^[@B16]^ Due to the similarity between *spib* and *spi1* and the elimination of primitive myeloid development in ^spib^e1i1~10ng~ and ^spib^ATG~10ng~ morphants, we investigated whether the posterior-erythroid compartment was affected in our *spib* morphant embryos. We assayed the state of primitive erythroid differentiation, using *globin, scl*, and *lmo2* expression, at stage 26, when erythroid differentiation is under way. Interestingly, no shift in the expression pattern of these genes into the anterior primitive myeloid compartment was detected, nor was a premature expression of hematopoietic genes in the posterior compartment (Figure S3). Therefore, when the differentiation of primitive myeloid cells was impaired, this did not result in an anterior shift or premature erythroid differentiation. Thus, we conclude that blocking myeloid differentiation, by eliminating *spib* function, did not interfere either with primitive erythroid lineage differentiation or the balance between primitive erythroid and myeloid-forming compartments as assayed by WMISH.

Retention of hemangioblast-like characteristics in *spib*-depleted embryos
--------------------------------------------------------------------------

One possible model to explain the phenotype we observed in *spib*-depleted embryos is that, as primitive myeloid progenitor differentiation is blocked, cell migration away from the aVBI is impaired and progenitor cells remain in an earlier state of hematopoietic differentiation. We first evaluated the migration of primitive myeloid cells in *spib* morphants by taking advantage of the range of phenotypes obtained with ^spib^e1i1~10ng~ and ^spib^ATG~10ng~ morphants. In stage 22 control embryos, migration away from the aVBI is well under way; however, in *spib*-depleted embryos, it is consistently absent ([Figure 7](#F7){ref-type="fig"}A-I). This result is particularly relevant if we compare the phenotype of *Xenopus spib* morphants with that of the zebrafish *spi1* morphants. In zebrafish when myeloid development is blocked by depletion of *spi1*, the defective primitive myeloid progenitor cells still migrate away from the ALPM.^[@B16]^ In contrast, our data indicate that *spib*-defective myeloid progenitor cells never migrate out of the aVBI. To analyze whether primitive progenitors were "stuck" in an earlier cellular stage of hematopoietic differentiation, we analyzed the expression of (1) postulated hemangioblast markers such as *scl* and *fli1*, (2) hematopoietic stem cell markers such as *scl, lmo2*, and *runx1*, (3) endothelial differentiation markers such as *fli1* and *kdr*, or (4) the erythroid marker *gata1*. We expected that modifications in the patterns of expression of these genes could provide insight in cell fate changes that occur when primitive myeloid development is blocked in vivo. In situ hybridization analysis of ^spib^e1i1~10ng~ and ^spib^ATG~10ng~ morphants indicated that a triangle-shaped expression domain of *scl* and *fli1* was retained at the border between aVBI and pVBI at stage 22, whereas all other markers analyzed to date were unaffected ([Figure 7](#F7){ref-type="fig"}J-O black and white arrowheads). In this small area, expression of *scl* and *fli1* has normally been down-regulated by stages 22 and 23 (compare [Figure 7](#F7){ref-type="fig"}J-K and M-N). Retention of *scl* and *fli1* expression is suggestive of retention of hemangioblast-like characteristics. However, this is a delay and not a permanent block in hematopoietic differentiation. At stage 26, no differences in the expression of *scl* and *fli1* can be observed between *spib*-depleted and control embryos (Figure S3 and data not shown). We also did not observe differences in the pattern of expression of the hematopoietic stem cell markers *runx1* and *lmo2*. Overall, these results suggest that in the absence of *spib* function primitive myeloid progenitors are blocked in their normal differentiation and migration, and they retain for a period of 2 to 3 hours hemangioblast-like characteristics in a small subset of aVBI cells, which would have otherwise differentiated into primitive myeloid cells.

![**Analysis of migratory potential and hemangioblast-like characteristics of primitive myeloid progenitors in *spib*-depleted embryos**. Migration away from the aVBI is the first morphologic sign of primitive myeloid differentiation and is absent in *spib*-depleted embryos. (A-I) In *spib*-depleted embryos, we never observed isolated cells far from the aVBI expressing *spib, mpo*, and *cebpa* at a time when migration should have already set in. Usual down-regulation of *scl* and *fli* (▿, J,M) is eliminated in *spib* morphants (▼, K,L and N,O). The *scl*^+^*fli*^+^ hemangioblast-like characteristics are maintained for longer in a small subset of *spib*-depleted aVBI tissue.](zh80180824210007){#F7}

Discussion
==========

Primitive myeloid cells are the first functional blood lineages in the embryo
-----------------------------------------------------------------------------

Blood cell development starts soon after the end of gastrulation, possibly under similar regulatory and signaling mechanisms that direct adult hematopoietic differentiation. However, there are clear differences between embryonic and adult hematopoiesis. For instance, differentiation of erythroid cells, evaluated by the expression of *globin* does not start until the mid--tailbud stages (ie, stages 24-25), which is about 12 hours after gastrulation. In addition, the vascular system is not functional until the early tadpole stages (ie, stage 35), which is yet another day later.^[@B42]^ Here we show that primitive myeloid cells become migratory at the end of the neurula stages (ie, stage 20). Furthermore, we found that these early differentiating myeloid lineages are functional, as they can respond to stimuli, such as embryonic wounds or bacterial infections, by quickly and efficiently migrating toward these sites. Therefore, our findings show that primitive myeloid cells are indeed the first blood lineages to become functional in the embryo, and they do so more than a day prior to the establishment of a functional vasculature. How heterogeneous this early population of myeloid cells is and what their varied functions are during development, repair, and embryonic immunity are of great interest, but these are questions that remain to be addressed.

*spib* is required to exit myeloid progenitor cell state
--------------------------------------------------------

In both zebrafish and *Xenopus*, a cell population of dorsal mesodermal origin transiently goes through a hemangioblast-like state, which at present is best characterized by an *scl* and *fli1* double-positive population of cells. These cells are believed to give rise to both vascular endothelium and blood lineages.^[@B12][@B13]--[@B14]^ In this work, we found a novel role for *spib* in the transition from a postulated *scl*^+^ *fli1*^+^ hemangioblast-like cell state into a migratory cell population leading to differentiation of embryonic macrophages and neutrophils. In particular, we found that blocking primitive myeloid differentiation and consequently their migration, through the loss of *spib* function, results in the maintenance of *scl* and *fli1* expression in the aVBI, suggesting that *spib* may be required for an exit of the hemangioblast-like state toward the primitive myeloid differentiation. This finding is distinct from the proposed role for *spi1* during primitive myelopoiesis in zebrafish, where *spi1* loss of function promotes erythroid specification at the expense of myeloid specification.^[@B16]^ In *Xenopus*, inhibition of *spib* does not lead to erythroid specification, instead, it leads to a delay in the exit of the progenitor state toward a pathway of myeloid differentiation.

*spib* is a key player in primitive myeloid development
-------------------------------------------------------

Here we show that *spib* is one of the earliest genes expressed in the progenitors of primitive myeloid cells in *Xenopus*, and we also show that *spib* is required for the specification and differentiation of primitive myeloid cells. A role for *Spib* in the hematopoietic system has been described in mice, in particular during the differentiation of B and dendritic cells of mice.^[@B43],[@B44]^ However, a role for *spib* during primitive myeloid differentiation is novel. *spib* is related to *spi1*, a well-known and essential gene for both primitive and definitive myelopoiesis.^[@B16],[@B45],[@B46]^ In mice, *Spi1* (official name, *Sfpi1*, but most commonly known as *Pu.1*) is required for the differentiation of all myeloid cells, even those originating from the yolk sac. However, in-depth evaluation of *Spi1*-null mice showed that *Spi1* is primarily required for terminal primitive myeloid differentiation in the yolk sac, as early markers of primitive myeloid cells, such as *GM-CSFR*, *G-CSFR*, and *MPO* are still present.^[@B41],[@B47]^ Consistent with this finding, we have found that inhibiting the function of *spi1* in *Xenopus tropicalis* does not affect the expression of early myeloid markers, such as *spib* and *mpo*, but does decrease the level of later myeloid markers, such as *mmp7* (R.M.B.C., X.S., and E.A., unpublished observation, May 2008). Thus, although very important for primitive myeloid differentiation, *spi1* is unlikely to be the sole player regulating primitive myeloid development. To this end, our findings show that *spib* functions upstream of *spi1* during primitive myeloid development based on its earlier expression pattern and the fact that *spi1* expression is dependent on *spib*. Furthermore, we found that early and late markers of primitive myeloid cells, with the exception of *cebpa*, were reduced or inhibited when *spib* function was knocked down. Whether *Spib* plays a similarly central role during primitive myeloid specification in mammals is an important question that will require further investigation.
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